Learn How the Insulin Cap for Seniors Works
Understanding the Insulin Cost Cap for Medicare Beneficiaries The insulin cost cap is a provision that affects how much Medicare beneficiaries pay out-of-poc...
Understanding the Insulin Cost Cap for Medicare Beneficiaries
The insulin cost cap is a provision that affects how much Medicare beneficiaries pay out-of-pocket for insulin prescriptions each year. Starting in 2023, Medicare Part D (prescription drug coverage) beneficiaries age 65 and older have a monthly cost limit of $35 for a one-month supply of insulin, regardless of the type or amount prescribed. This represents a significant change in Medicare drug pricing rules and was established through federal legislation.
Before this change, seniors could face substantial costs for insulin. Prior to 2023, some beneficiaries reported paying $400 to $600 or more per month for insulin without cost protections. The cap applies to all insulin formulations, including rapid-acting, long-acting, and intermediate-acting insulins. This rule affects approximately 3.4 million Medicare Part D beneficiaries who use insulin to manage diabetes.
The cap does not apply to all diabetes medicationsâonly insulin products are covered under this specific rule. Other diabetes drugs like GLP-1 receptor agonists or SGLT2 inhibitors have different coverage rules under Medicare Part D. Additionally, the cap applies only to those with Medicare Part D coverage. Medicare Advantage beneficiaries (Part C plans that include drug coverage) may have different insulin cost structures depending on their specific plans.
Understanding what this cap covers and how it functions helps seniors make informed decisions about their prescription drug coverage. The cap represents a floor on cost protection, meaning beneficiaries will pay no more than $35 monthly for insulin, but they may pay less depending on their specific plan design and cost-sharing structure.
Practical Takeaway: Review your Medicare Part D plan documents or call your plan's customer service to understand how the $35 monthly insulin cap applies to your specific prescriptions and any additional out-of-pocket costs you may owe.
How the $35 Monthly Cap Works in Practice
The mechanics of the insulin cost cap operate at the point of sale in a pharmacy. When a Medicare Part D beneficiary fills a prescription for insulin, the pharmacist applies the beneficiary's cost-sharing obligations according to their specific plan. Once the total amount the beneficiary has paid for insulin in a given month reaches the $35 threshold, they pay no additional cost for insulin refills that same month.
The cap applies to calendar months, meaning the counter resets on the first day of each new month. If you fill an insulin prescription on January 15th and pay $25 toward the cap, you have $10 of your cap remaining for January. If you fill another insulin prescription on January 25th and the normal cost-sharing would be $20, you would only pay $10 (the remaining amount of your cap), and the plan would cover the other $10. Starting February 1st, your cap resets to $35.
Different Medicare Part D plans have different cost-sharing structures, which affects how quickly you reach the $35 cap. Some plans charge a flat copay for each insulin prescriptionâfor example, $5 or $10 per fill. Other plans use coinsurance, requiring you to pay a percentage of the actual drug cost. Some plans charge copays in earlier benefit phases and coinsurance in later phases. Your specific plan determines how much you pay with each fill until you reach $35.
The cap applies to the entire month of fill dates, not to a 30-day rolling period. This means that the timing of when you fill prescriptions during a calendar month affects your out-of-pocket costs. Someone who fills insulin on the last day of the month may only use a small portion of their $35 cap in that month, leaving the remainder unused.
Practical Takeaway: Contact your pharmacy or Medicare plan to understand your plan's specific copay or coinsurance amounts for insulin, so you can estimate how many fills you might need to reach your $35 monthly cap.
Coverage Details and What Insulin Types Are Included
The $35 insulin cap covers all U.S. Food and Drug Administration (FDA)-approved insulin products available through Medicare Part D. This includes insulin administered by injection (subcutaneous injection) with pens, syringes, or vials, as well as insulin administered through pumps. The cap covers insulin regardless of the medication's brand name, manufacturer, or formulation type.
Common insulin types covered include NPH insulin (intermediate-acting), regular insulin (short-acting), insulin lispro, insulin aspart, insulin glulisine (rapid-acting), insulin detemir, insulin glargine, and insulin degludec (long-acting), among others. Insulin combination productsâsuch as 70/30 insulin or 50/50 insulinâare also covered. Biosimilar insulins, which are FDA-approved versions of biologic insulin products, receive the same $35 cap as their reference products.
The cap specifically covers insulin but does not extend to other diabetes-related supplies or medications. Supplies like syringes, needles, alcohol swabs, lancets for blood glucose testing, and test strips are not subject to this cap. Other diabetes medications such as metformin, sulfonylureas, GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, and thiazolidinediones follow standard Medicare Part D cost-sharing rules without this $35 monthly limit.
Coverage applies only to insulin obtained through Medicare Part Dâthe prescription drug coverage offered with Original Medicare (Parts A and B) or through some Medicare Advantage plans that include drug coverage. Those with employer-sponsored insurance, Medicaid, Veterans Affairs coverage, or other insurance programs may have different insulin cost protections or limitations.
Practical Takeaway: Confirm with your pharmacy or doctor whether your specific insulin prescription is covered under your Medicare Part D plan, and ask about supplies or other diabetes medications you take to understand their separate cost-sharing rules.
Who This Cap Applies To and Coverage Gaps
The $35 monthly insulin cap applies to Medicare beneficiaries age 65 and older who have Medicare Part D prescription drug coverage. This includes individuals with Original Medicare (Parts A and B) who have enrolled in a standalone Part D plan, as well as those with a Medicare Advantage plan that includes prescription drug coverage (Part D). The cap applies regardless of household income levelâeven high-income beneficiaries receive this protection.
As of 2024, the cap applies to approximately 3.4 million Medicare Part D beneficiaries who take insulin. However, not all seniors with Medicare have Part D coverage. Those with Original Medicare who have not enrolled in a Part D plan are not covered. Additionally, those with only Medicare Advantage Part C coverage without drug benefits are not covered by this cap. Those enrolled in Medicaid (the joint federal-state insurance program for lower-income individuals) have different insulin cost protections under their state programs and do not fall under the Medicare Part D cap.
Coverage gaps exist for certain populations. Medicare beneficiaries under age 65 (such as those with End-Stage Renal Disease or certain disabilities) may access insulin through Medicare Part B rather than Part D, and those beneficiaries may have different cost-sharing structures. Those with group health insurance from an employer, those covered by TRICARE (Department of Defense insurance), those with Veterans Affairs coverage, and those with Indian Health Service coverage are all outside the Medicare Part D system and are not subject to this cap.
Additionally, the cap does not cover insulin obtained outside the Medicare Part D pharmacy network, through mail-order services that are not part of the plan, or through other third-party arrangements. If a beneficiary uses a non-network pharmacy or obtains insulin through non-standard channels, the claims may not apply toward the $35 cap.
Practical Takeaway: Verify that your Medicare coverage includes Part D prescription drug benefits by reviewing your Medicare Summary Notice or calling Medicare directly at 1-800-MEDICARE to confirm whether the insulin cap applies to your coverage.
Planning Your Prescriptions and Managing Costs Throughout the Year
Once you reach the $35 monthly cap for insulin, you have full coverage with no additional cost-sharing for the remainder of that month. This means that beneficiaries who use multiple insulin types or who have frequent refills will reach the $35 cap in some months and may not in others. Planning your prescription refills can help you understand your expected out-of-pocket costs across different months.
Many beneficiaries use multiple insulin
Related Guides
More guides on the way
Browse our full collection of free guides on topics that matter.
Browse All Guides â